CHRM2 and Cowden disease: Functional autoantibodies (AAb) against β1 and β2 adrenergic receptors (β1AR/β2AR) [3,4,5] and M2 muscarinic acetylcholine receptors (M2R) have been identified in patients with chronic CD.